Skip to content

PROXY PHARMA: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

PROXY PHARMA

BE 0673.992.721
NACE 47.730, Retail sale of pharmaceutical products
NACE division 47, Retail trade all sizesfiscal years 2020 to 202421,483 to 41,307 sector peers per ratio

Summary

fiscal year 2024

PROXY PHARMA does better than half of its sector on 1 of the 9 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Return on equitybetter than 72%
Points to watch
  • Debt to equitybetter than 5%
  • Long-term debt ratiobetter than 5%
  • Solvencybetter than 19%

Solvency and debt

How soundly the company is financed.
Solvency
3.7%▼2024

Solvency is below 81% of 41,204 sector peers: in the least favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
Debt to equity
26.12▲2024

Debt to equity is above 95% of 40,686 sector peers: in the least favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
Long-term debt ratio
13.42▲2024

The long-term debt ratio is above 95% of 21,483 sector peers: in the least favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
Interest coverage
5.93▼2024

Interest coverage is below 57% of 36,771 sector peers: less favourable than the median.

Position against the sector stable since 2020.

20202021202220232024

Liquidity

Whether it can pay its short-term bills.
Current ratio
0.99▼2024

The current ratio is below 71% of 41,060 sector peers: less favourable than the median.

Position against the sector stable since 2020.

20202021202220232024
Quick ratio
0.70▼2024

The quick ratio is below 58% of 41,086 sector peers: less favourable than the median.

Position against the sector stable since 2020.

20202021202220232024
Working-capital ratio
-0.2%▼2024

The working-capital ratio is below 72% of 41,134 sector peers: less favourable than the median.

Position against the sector stable since 2020.

20202021202220232024

Profitability

What the company earns on its assets and its sales.
Return on equity
27.9%▼2024

Return on equity is above 72% of 33,958 sector peers: more favourable than the median.

Position against the sector stable since 2020.

20202021202220232024
Return on assets
1.0%▼2024

Return on assets is below 64% of 41,307 sector peers: less favourable than the median.

Position against the sector weakening since 2020.

20202021202220232024

Not computable

Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. The filed figures do not contain the lines these need.

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 28 September 2026 via checked.be.